Showing results (111-120 of 5,694) with videos related to
Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|June 18, 2015
Influence of video-assisted thoracoscopic lobectomy on immunological functions in non-small cell lung cancer patientsLian-Bin Zhang, Bo Wang, Xu-Yi Wang, et al.Medical Oncology (Northwood, London, England)|June 20, 2015
MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabineJeng-Wei Lu, Yu-Min Lin, Yen-Ling Lai, et al.Medical Oncology (Northwood, London, England)|February 4, 2018
Expression of gremlin1 in gastric cancer and its clinical significanceYoichi Yamasaki, Sumiya Ishigami, Takaaki Arigami, et al.Medical Oncology (Northwood, London, England)|March 23, 2018
Gemcitabine-cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forwardVikas Ostwal, Rohit Swami, Shraddha Patkar, et al.Medical Oncology (Northwood, London, England)|March 30, 2018
Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRTV Dell'Acqua, J Kobiela, F Kraja, et al.Medical Oncology (Northwood, London, England)|February 10, 2018
A phase I study of afatinib for patients aged 75 or older with advanced non-small cell lung cancer harboring EGFR mutationsHisashi Tanaka, Kageaki Taima, Yoshihito Tanaka, et al.Medical Oncology (Northwood, London, England)|February 2, 2018
Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA)Emeline Moreira, Eduardo Paulino, Álvaro Henrique Ingles Garces, et al.Medical Oncology (Northwood, London, England)|February 2, 2018
Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissectionsDaniel E Spratt, Krithika Suresh, Takahiro Osawa, et al.Medical Oncology (Northwood, London, England)|December 31, 2017
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomasRoberto Castelli, Luigi Bergamaschini, Giorgio Lambertenghi DeliliersMedical Oncology (Northwood, London, England)|March 10, 2018
SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangementMałgorzata Szostakowska, Michał Szymczyk, Kalina Badowska, et al.Pageof 570